Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 125.3 million in the first quarter of 2025 (Q1 2024: NOK ...

Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research ...

Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.

Bladder cancer has earned the title as the "forgotten cancer" despite being the fifth most common in Canada. According to the Canadian Cancer Society, it's estimated that in 2024, 12,300 Canadians ...

THIS YEAR the Spanish capital, Madrid, provided the backdrop for Europe’s biggest urological event, the 40th Annual European ...

This year, what happens in Vegas benefits the Urology Care Foundation! Please join us at the iconic Venetian hotel for a night of pure magic. Don't forget your masquerade mask because we're ...

In a previous interview with Urology Times®, Li described the trial: “In the MoonRISe-1 study, we're studying the efficacy of TAR-210 to prevent recurrence within the bladder by inserting the TAR-210 ...

Asked about the take-home message of the study, Xu said, “I think the take-home message for the practicing urologist would really be just to know that programs such as the Mark Cuban Cost Plus Drug ...

This is an inspection of the bladder and the urethra using a cystoscope. There are two types of cystoscope: Rigid: A solid telescope which has a light and a separate channel to allow other ...

The advent of optical (i.e. laparoscopy, cystoscopy) and fluoroscopic ... imaging capabilities not available to the practicing urologist until now. The enhanced capability of intraoperative ...

She received a course of oral ciprofloxacin. Four days before the current admission, cystoscopy revealed evidence of mild radiation cystitis, blood clots, and a new 1.5-cm tumor on the left ...